20.07.2016
- Roche’s new blood cancer drug Gazyva has failed to show significant improvements in a late-stage lymphoma trial, delivering a blow to its plans for a successor to blockbuster drug...
06.11.2013
- Swiss pharmaceutical giant Roche has received the green light from the U.S. Food and Drug Adminstration (FDA) to sell Gazyva (obinutuzumab), its new agent to treat chronic...
